Telacebec (Q203), a New Antituberculosis Agent.
de Jager VR, Dawson R, van Niekerk C, Hutchings J, Kim J, Vanker N, van der Merwe L, Choi J, Nam K, Diacon AH.
de Jager VR, et al. Among authors: hutchings j.
N Engl J Med. 2020 Mar 26;382(13):1280-1281. doi: 10.1056/NEJMc1913327.
N Engl J Med. 2020.
PMID: 32212527
Clinical Trial.
No abstract available.